Related Experiment Video
Updated: Aug 14, 2026
12:24
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
What do patients consider when making decisions about treatment for hepatitis C?
Liana Fraenkel1, Sarah McGraw, Suchat Wongcharatrawee
1Department of Medicine, VA Connecticut Healthcare System, West Haven, Conn, USA. liana.fraenkel@yale.edu
The American Journal of Medicine
|December 28, 2005
Summary
Patient decisions for hepatitis C treatment involve more than just risk-benefit analysis. Factors like personal values, illness perception, and social concerns significantly influence choices, impacting treatment adherence.
Area of Science:
- Hepatology
- Patient Decision-Making
- Behavioral Science
Background:
- Limited understanding of patient perspectives in chronic hepatitis C treatment decisions.
- Need to explore factors beyond clinical data influencing patient choices.
Purpose of the Study:
- Investigate patient-specific factors influencing treatment decisions for hepatitis C infection.
- Identify key influences on treatment choices from the patient's viewpoint.
Main Methods:
- Focus groups conducted with 40 patients undergoing or refusing hepatitis C treatment.
- Purposeful sampling ensured diverse patient experiences were captured.
- Thematic saturation and constant comparative methods guided data analysis.
Main Results:
- Key decision-making factors include risk-benefit trade-offs, protected values, and heuristics.
- Patients' conceptualization of hepatitis C and social issues significantly impact choices.
- Physician recommendations play a role, but are weighed against other personal factors.
Conclusions:
- Hepatitis C treatment decisions are multifactorial, extending beyond clinical risks and benefits.
- Physicians should address patient heuristics, illness perceptions, and social concerns to enhance decision-making.
- Understanding these factors can improve patient engagement and adherence to hepatitis C therapy.
Related Concept Videos
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:27Nursing Ethical Principles II
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's cancer...
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's cancer...
01:28Esophageal Varices-II: Clinical Features and Management
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...